Rodriguez De Fonseca; Fernando Antonio
Patent Applications and Registrations
Patent applications and USPTO patent grants for Rodriguez De Fonseca; Fernando Antonio.The latest application filed is for "1,2,4-oxadiazole derivatives as drugs modulating the glp-1 peptide receptor".
- Rodriguez De Fonseca; Fernando Antonio - Malaga N/A ES
| Patent | Date |
|---|---|
| 1,2,4-oxadiazole derivatives as drugs modulating the GLP-1 peptide receptor Grant 9,050,347 - Rodriguez De Fonseca , et al. June 9, 2 | 2015-06-09 |
| 1,2,4-oxadiazole Derivatives As Drugs Modulating The Glp-1 Peptide Receptor App 20140031347 - Rodriguez De Fonseca; Fernando Antonio ; et al. | 2014-01-30 |
| Acyclic Sulfamide Derivatives App 20100179224 - RODRIGUEZ DE FONSECA; Fernando Antonio ; et al. | 2010-07-15 |
| Acyclic Sulfamide Derivatives App 20100048712 - RODRIGUEZ DE FONSECA; Fernando Antonio ; et al. | 2010-02-25 |
| Acyclic Sulfamide Derivatives App 20090221710 - Rodriguez De Fonseca; Fernando Antonio ; et al. | 2009-09-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 